Fibromyalgia Treatment Market Size, Trends, Share, Growth, and Opportunity Forecast, 2023 - 2030 Global Industry Analysis by Treatment Type (Medication (Pain relievers, Antidepressants, Anticonvulsants, Muscle relaxants, and Others), Therapies (Physical therapy, Occupational therapy, Cognitive-behavioral therapy (CBT), Acupuncture, and Other), and Non-Pharmacological Approaches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and by Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

By Treatment Type

·         Medication

o   Pain relievers

o   Antidepressants

o   Anticonvulsants

o   Muscle relaxants

o   Others

·         Therapies

o   Physical therapy

o   Occupational therapy

o   Cognitive-behavioral therapy (CBT)

o   Acupuncture

o   Others

·         Non-Pharmacological Approaches

By Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

·         Others

By Geography

·         North America

·         Europe

·         Asia Pacific

·         South America

·         Middle East & Africa

Companies Profiled

·         Pfizer Inc.

·         Eli Lilly and Company

·         Johnson & Johnson

·         Novartis AG

·         AbbVie Inc.

·         GlaxoSmithKline plc

·         Merck & Co., Inc.

·         Sanofi S.A.

·         Teva Pharmaceutical Industries Ltd.

·         AstraZeneca plc

·         Bristol Myers Squibb Company

·         Boehringer Ingelheim International GmbH

·         Mylan N.V.

·         Endo International plc